Clinical Trial Update: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and immunogenicity of a booster dose of GBS6 polysaccharide conjugate vaccine in healthy adults; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infections

Drugs mentioned

• GBS6

Snippet

Sponsor: Pfizer | Conditions: Group B Streptococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-10-13